Table 4.
Treatments of patients with MPP.
| Treatments, n (%) | Normal group (n=106) | Mild-moderately elevated group (n=204) | Severely elevated group (n=46) | P-value |
|---|---|---|---|---|
| Oxygen therapy | 28 (26.4%) | 46 (22.5%) | 24 (52.2%) b#,c# | 0.000 |
| Glucocorticoid | 51 (48.1%) | 150 (73.5%) a# | 44 (95.7%) b#,c# | 0.000 |
| Bronchoscope | 21 (19.8%) | 110 (53.9%) a# | 40 (87.0%) b#,c# | 0.000 |
| immunoglobulin | 3 (2.8%) | 10 (4.9%) | 14 (30.4%) b#,c# | 0.000 |
| ICU | 0 (0.0%) | 2 (1.0%) | 8 (17.4%) b#,c# | 0.000 |
| Mechanical ventilation | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 |
| Thoracentesis | 0 (0.0%) | 15 (7.4%) a# | 19 (41.3%) b#,c# | 0.000 |
Data are presented as number (percentage). #P < 0.01; acompared between normal group and mild-moderately elevated group; bcompared between normal group and severely elevated group; ccompared between mild-moderately elevated group and severely elevated group.